KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Asset Writedowns and Impairment (2020 - 2024)

Vir Biotechnology's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $11.0 million for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment rose 300.07% to $11.0 million in Q4 2024 year-over-year; TTM through Dec 2025 was $11.0 million, a 20.0% decrease, with the full-year FY2024 number at $14.6 million, up 50.65% from a year prior.
  • Asset Writedowns and Impairment hit $11.0 million in Q4 2024 for Vir Biotechnology, up from $2.8 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for VIR hit a ceiling of $11.0 million in Q4 2024 and a floor of $800000.0 in Q3 2020.
  • Historically, Asset Writedowns and Impairment has averaged $4.9 million across 3 years, with a median of $2.8 million in 2023.
  • The widest YoY moves for Asset Writedowns and Impairment: up 300.07% in 2024, down 300.07% in 2024.
  • Tracing VIR's Asset Writedowns and Impairment over 3 years: stood at $800000.0 in 2020, then surged by 244.88% to $2.8 million in 2023, then soared by 300.07% to $11.0 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for VIR at $11.0 million in Q4 2024, $2.8 million in Q4 2023, and $800000.0 in Q3 2020.